Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)

Houston, Texas, USA  All United States companies → — Founded 2017
Imaging AI Specialist Specialty-Focused AI
Seed

Products

RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.

See all 1 product →

About Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)

InformAI is a healthcare AI company that develops AI-driven enterprise software solutions, specializing in critical fields such as radiology, radiation oncology, and high-acuity informatics. It provides AI-guided dose prediction from CT simulations and clinician-defined treatment-planning structures for adult head-and-neck malignant or benign disease. The software aims to generate optimized radiation plans that target tumors while minimizing exposure to adjacent healthy tissues, ultimately improving consistency, efficiency, quality, and safety in radiation oncology workflows.

Beyond RadOncAI, InformAI’s product pipeline includes TransplantAI and SinusAI. TransplantAI is a donor-recipient informatics platform that leverages AI to enable granular transplant decisions at the point of care, addressing organ scarcity and allocation inefficiency. SinusAI is designed to advance CT imaging diagnostics with AI-enabled precision and efficiency. InformAI’s solutions are developed to integrate into hospital workflows and existing reimbursement frameworks, with a focus on solving workflow bottlenecks, accelerating diagnosis and decision-making, and improving clinician productivity.

Focus Areas

radiology radiation oncology transplant decision support CT diagnostics AI-driven clinical software medical imaging patient outcome prediction

Business Intelligence

TechnologyAI-driven enterprise software, AI-enabled image classifiers, patient outcome predictors, machine learning, deep learning

What Physicians Need to Know

Specialization: Radiation Oncology
InformAI's flagship product, RadOncAI, is an AI-enabled software for radiation therapy dose planning, specifically for head and neck cancer patients. It optimizes treatment dose plans to target tumors while minimizing exposure to healthy tissues.
Specialization: Transplant Decision Support
TransplantAI is a donor-recipient informatics platform that utilizes AI to enable granular transplant decisions at the point of care. It leverages data from over 500 parameters per organ and CT images to enhance decision-making for heart and lung transplant outcomes.
Specialization: CT Diagnostics
SinusAI is a product in InformAI's pipeline that aims to advance CT imaging diagnostics with AI-enabled precision and efficiency.
Key Differentiator: Clinical Focus & Fit-for-Purpose Products
InformAI emphasizes targeted solutions for specific clinical pain points rather than one-size-fits-all imaging AI.
Key Differentiator: Enterprise-Grade Integration
The company develops scalable, enterprise software designed to integrate into hospital workflows and existing reimbursement frameworks.
Key Differentiator: Clinical Provenance & Partnerships
Product development is tied to the Texas Medical Center ecosystem, ensuring clinical relevance.
Technology Stack: AI/Machine Learning/Deep Learning
InformAI develops sophisticated machine learning and deep learning products to enhance clinical decision-making, optimize treatment planning, and improve patient outcomes. Their products are AI-driven enterprise software solutions.
Regulatory Status
InformAI has received FDA 510(k) clearance for its RadOncAI radiation dose planning software-as-a-medical-device (SaMD).
Physician Tip

For physicians, InformAI's products, like RadOncAI, offer the potential for generating high-quality radiation dose plans more efficiently, assisting in delivering optimized and clinically achievable plans in a fraction of the time. This can lead to substantial clinical productivity and cost savings. The AI-driven tools aim to improve consistency, efficiency, quality, and safety in radiation care by providing expert-level plans, generating plans in minutes, improving IMRT/VMAT protocols, and reducing off-target radiation. For transplant specialists, TransplantAI provides real-time predictive insights for donor-recipient matching, assessing multi-outcome risks, and improving transplant matching and patient outcomes. The company's focus on 'fit-for-purpose' AI means their solutions are designed to address specific clinical pain points, aiming to accelerate diagnosis, improve clinician productivity, and provide decision support that integrates into existing hospital workflows.

InformAI's enterprise-grade software is designed for seamless and scalable integration into hospital workflows and existing reimbursement frameworks. RadOncAI, for instance, accepts CT simulation, target, and organ-at-risk inputs and exports DICOM RT Dose to compatible treatment-planning or DICOM-RT workflows. They partner with elite medical institutions and deploy directly with channel partners. Strategic partners include Nvidia's Inception Program, Microsoft for Startups, and Amazon Activate.

Products by Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)

1 product in the directory

RadOncAI
Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net)
Oncology AI
RadOncAI is an AI solution by Informai designed to optimize and enhance radiation oncology workflows, improving efficiency and accuracy in treatment planning and delivery.

Videos

News, demos, and interviews about Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net).

Loading videos...

Videos load interactively. If none appear, search YouTube for Informai (for RadOncAI product) / Global Network for AI in Radiation Oncology (for RadoncAI.net) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Informai's RadOncAI product aims to enhance precision and efficiency in radiation oncology by leveraging AI for tasks such as treatment planning, contouring, and patient outcome prediction. It is designed to integrate with standard DICOM-compliant imaging systems and existing oncology information systems to minimize disruption to current clinical workflows.
RadOncAI.net serves as a collaborative platform for advancing AI in radiation oncology, enabling researchers and clinicians to share insights and potentially de-identified data. The network prioritizes patient data privacy through robust anonymization protocols and strict adherence to international data protection regulations such as HIPAA and GDPR, ensuring secure and ethical data exchange.
Informai employs rigorous validation methodologies for its AI-driven software, including extensive retrospective and prospective studies to demonstrate clinical efficacy and safety. For patient outcome prediction and transplant decision support, the company collaborates with leading medical institutions to validate algorithms against real-world patient data and clinical endpoints.
Informai offers flexible pricing models for RadOncAI, which can include subscription-based licensing or per-use fees, tailored to the needs of individual healthcare providers. Comprehensive support services are provided, encompassing initial implementation and staff training, dedicated technical assistance, and continuous software updates and maintenance to ensure optimal performance.
Informai has forged strategic partnerships with key medical technology companies and prominent research institutions to enhance its AI capabilities and expand its reach. These collaborations foster innovation, facilitate the integration of RadOncAI with diverse healthcare platforms, and contribute to the company's long-term stability and competitive advantage in the market.
Informai addresses the 'black box' concern by developing AI models that prioritize interpretability and transparency, especially in critical applications like CT diagnostics and radiation dose planning. The company provides tools and interfaces that allow clinicians to understand the rationale behind AI-generated recommendations, fostering trust and enabling informed clinical decisions.
Informai's long-term vision for RadOncAI and RadOncAI.net is to establish a leading global ecosystem for AI-driven solutions in radiation oncology, continuously advancing treatment precision and patient outcomes. The company also explores strategic expansion into other medical imaging and diagnostic areas, leveraging its core AI expertise to address broader clinical needs and improve healthcare delivery.

Related Companies

Radin Health offers a comprehensive suite of AI-powered, cloud-based solutions designed to enhance operational efficiency across all stages of the radiology workflow. Their platform integrates a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-driven Dictation, and RADIN SELECT for workflow management. These solutions aim to improve efficiency and productivity for administrators, medical […]

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.